287 related articles for article (PubMed ID: 37893530)
1. Exploring Medicinal Herbs' Therapeutic Potential and Molecular Docking Analysis for Compounds as Potential Inhibitors of Human Acetylcholinesterase in Alzheimer's Disease Treatment.
Farihi A; Bouhrim M; Chigr F; Elbouzidi A; Bencheikh N; Zrouri H; Nasr FA; Parvez MK; Alahdab A; Ahami AOT
Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893530
[No Abstract] [Full Text] [Related]
2. Acetylcholinesterase inhibition of Alzheimer's disease: identification of potential phytochemicals and designing more effective derivatives to manage disease condition.
Koly HK; Sutradhar K; Rahman MS
J Biomol Struct Dyn; 2023; 41(22):12532-12544. PubMed ID: 36651199
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
[TBL] [Abstract][Full Text] [Related]
4. A computational approach to identify phytochemicals as potential inhibitor of acetylcholinesterase: Molecular docking, ADME profiling and molecular dynamics simulations.
Azmal M; Hossen MS; Shohan MNH; Taqui R; Malik A; Ghosh A
PLoS One; 2024; 19(6):e0304490. PubMed ID: 38833492
[TBL] [Abstract][Full Text] [Related]
5. De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer's Agents.
Pandey S; Singh BK
Curr Comput Aided Drug Des; 2020; 16(1):54-72. PubMed ID: 30827255
[TBL] [Abstract][Full Text] [Related]
6. Identification of Natural Compounds of the Apple as Inhibitors against Cholinesterase for the Treatment of Alzheimer's Disease: An In Silico Molecular Docking Simulation and ADMET Study.
Jamal QMS; Khan MI; Alharbi AH; Ahmad V; Yadav BS
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049419
[TBL] [Abstract][Full Text] [Related]
7. Designing Second Generation Anti-Alzheimer Compounds as Inhibitors of Human Acetylcholinesterase: Computational Screening of Synthetic Molecules and Dietary Phytochemicals.
Amat-Ur-Rasool H; Ahmed M
PLoS One; 2015; 10(9):e0136509. PubMed ID: 26325402
[TBL] [Abstract][Full Text] [Related]
8. Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents.
Ambure P; Kar S; Roy K
Biosystems; 2014 Feb; 116():10-20. PubMed ID: 24325852
[TBL] [Abstract][Full Text] [Related]
9. Traditional Chinese medicinal herbs as potential AChE inhibitors for anti-Alzheimer's disease: A review.
Jiang Y; Gao H; Turdu G
Bioorg Chem; 2017 Dec; 75():50-61. PubMed ID: 28915465
[TBL] [Abstract][Full Text] [Related]
10. In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment.
Ali B; Jamal QM; Shams S; Al-Wabel NA; Siddiqui MU; Alzohairy MA; Al Karaawi MA; Kesari KK; Mushtaq G; Kamal MA
CNS Neurol Disord Drug Targets; 2016; 15(5):624-8. PubMed ID: 26996169
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, extra-precision docking, and molecular dynamics simulation studies of pyrrolidin-2-one derivatives as potential acetylcholinesterase inhibitors.
Gupta M; Kumar A; Prasun C; Nair MS; Kini SG; Yadav D; Nain S
J Biomol Struct Dyn; 2023; 41(13):6282-6294. PubMed ID: 35921217
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
Son M; Park C; Rampogu S; Zeb A; Lee KW
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
[TBL] [Abstract][Full Text] [Related]
13. In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer's Disease.
Iman K; Mirza MU; Mazhar N; Vanmeert M; Irshad I; Kamal MA
CNS Neurol Disord Drug Targets; 2018 Apr; 17(1):54-68. PubMed ID: 29336270
[TBL] [Abstract][Full Text] [Related]
14. An
Potshangbam AM; Nandeibam A; Amom T; Potshangbam N; Rahaman H; Rathore RS; Singh LR; Khan A
J Biomol Struct Dyn; 2022 Mar; 40(4):1521-1533. PubMed ID: 33021148
[TBL] [Abstract][Full Text] [Related]
15. Molecular networking based dereplication of AChE inhibitory compounds from the medicinal plant
Abbas-Mohammadi M; Moridi Farimani M; Salehi P; Ebrahimi SN; Sonboli A; Kelso C; Skropeta D
J Biomol Struct Dyn; 2022 Mar; 40(5):1942-1951. PubMed ID: 33054569
[TBL] [Abstract][Full Text] [Related]
16. A Review on Recent Approaches on Molecular Docking Studies of Novel Compounds Targeting Acetylcholinesterase in Alzheimer Disease.
Peitzika SC; Pontiki E
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770750
[TBL] [Abstract][Full Text] [Related]
17. Molecular modeling of multi-target analogs of huperzine A and applications in Alzheimer's disease.
de Sousa LF; Paschoal DFS; Novato WTG
J Mol Model; 2024 Jun; 30(7):200. PubMed ID: 38850372
[TBL] [Abstract][Full Text] [Related]
18. Proposing novel natural compounds against Alzheimer's disease targeting acetylcholinesterase.
Girgin M; Isik S; Kantarci-Carsibasi N
PLoS One; 2023; 18(4):e0284994. PubMed ID: 37104478
[TBL] [Abstract][Full Text] [Related]
19. Identification of Potent Acetylcholinesterase Inhibitors as New Candidates for Alzheimer Disease via Virtual Screening, Molecular Docking, Dynamic Simulation, and Molecular Mechanics-Poisson-Boltzmann Surface Area Calculations.
Chennai HY; Belaidi S; Bourougaa L; Ouassaf M; Sinha L; Samadi A; Chtita S
Molecules; 2024 Mar; 29(6):. PubMed ID: 38542869
[TBL] [Abstract][Full Text] [Related]
20. Computational Investigation of Novel Compounds as Dual Inhibitors of AChE and GSK-3β for the Treatment of Alzheimer's Disease.
Londhe SG; Shenoy M; Kini SG; Walhekar V; Kumar D
Curr Top Med Chem; 2024 Jun; ():. PubMed ID: 38859777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
